Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing - PubMed (original) (raw)

Randomized Controlled Trial

. 2015 Oct 1;61(7):1071-80.

doi: 10.1093/cid/civ447. Epub 2015 Jul 20.

Affiliations

Randomized Controlled Trial

Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing

Ritu Banerjee et al. Clin Infect Dis. 2015.

Abstract

Background: The value of rapid, panel-based molecular diagnostics for positive blood culture bottles (BCBs) has not been rigorously assessed. We performed a prospective randomized controlled trial evaluating outcomes associated with rapid multiplex PCR (rmPCR) detection of bacteria, fungi, and resistance genes directly from positive BCBs.

Methods: A total of 617 patients with positive BCBs underwent stratified randomization into 3 arms: standard BCB processing (control, n = 207), rmPCR reported with templated comments (rmPCR, n = 198), or rmPCR reported with templated comments and real-time audit and feedback of antimicrobial orders by an antimicrobial stewardship team (rmPCR/AS, n = 212). The primary outcome was antimicrobial therapy duration. Secondary outcomes were time to antimicrobial de-escalation or escalation, length of stay (LOS), mortality, and cost.

Results: Time from BCB Gram stain to microorganism identification was shorter in the intervention group (1.3 hours) vs control (22.3 hours) (P < .001). Compared to the control group, both intervention groups had decreased broad-spectrum piperacillin-tazobactam (control 56 hours, rmPCR 44 hours, rmPCR/AS 45 hours; P = .01) and increased narrow-spectrum β-lactam (control 42 hours, rmPCR 71 hours, rmPCR/AS 85 hours; P = .04) use, and less treatment of contaminants (control 25%, rmPCR 11%, rmPCR/AS 8%; P = .015). Time from Gram stain to appropriate antimicrobial de-escalation or escalation was shortest in the rmPCR/AS group (de-escalation: rmPCR/AS 21 hours, control 34 hours, rmPCR 38 hours, P < .001; escalation: rmPCR/AS 5 hours, control 24 hours, rmPCR 6 hours, P = .04). Groups did not differ in mortality, LOS, or cost.

Conclusions: rmPCR reported with templated comments reduced treatment of contaminants and use of broad-spectrum antimicrobials. Addition of antimicrobial stewardship enhanced antimicrobial de-escalation.

Clinical trials registration: NCT01898208.

Keywords: PCR; antimicrobial stewardship; blood culture; diagnostic.

© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

PubMed Disclaimer

Figures

Figure 1.

Figure 1.

Participant enrollment. System/technical errors included randomization software downtime, typographical errors causing an ineligible subject to be erroneously randomized, and failure to enter an eligible subject into the randomization program. Abbreviation: PCR, polymerase chain reaction.

Figure 2.

Figure 2.

Comparison of time to organism identification, availability of phenotypic antimicrobial susceptibility results, and first appropriate modification of antimicrobial therapy for the subset of study subjects with organisms represented on the rapid multiplex polymerase chain reaction (rmPCR) panel (n = 481). Time 0 is when the positive Gram stain result was reported. Median time in hours (interquartile range [IQR]) to organism identification: control 22.3 (17–28), both rmPCR and rmPCR + stewardship 1.3 (0.9–1.6); de-escalation: control 39 (19–56), rmPCR 36 (22–61), rmPCR + stewardship 20 (6–36); escalation: control 18 (2–63), rmPCR 4 (1.5–24), rmPCR + stewardship 4 (1.8–9). *P < .05 vs control; †P < .05 vs control and rmPCR groups.

Comment in

Similar articles

Cited by

References

    1. Ibrahim E, Sherman G, Ward S, Fraser V, Kollef M. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:46–55. - PubMed
    1. Garnacho-Montero J, Gutierrez-Pizarraya A, Escoresca-Ortega A et al. . De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med 2014; 40:32–40. - PubMed
    1. Dellit T, Owens R, McGowan J et al. . Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an an institutional program for enhancing antimicrobial stewardship. Clin Infect Dis 2007; 44:159–77. - PubMed
    1. Caliendo A, Gilbert D, Ginocchio C et al. . Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis 2013; 57:S139–70. - PMC - PubMed
    1. Perez K, Olsen R, Musick W et al. . Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med 2012; 137:1247–54. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources